Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Three Therapeutic Options for COPD
NCT04520230Phase 4Completed
- Sponsor
- Tanta University
- Start
- Oct 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of EPI-EE, formoterol, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Tanta University. Started Oct 2014; status: completed.
02
Drugs
EPI-EEformoteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04520230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520230.